|
changing Section 370c as follows:
|
(215 ILCS 5/370c) (from Ch. 73, par. 982c)
|
Sec. 370c. Mental and emotional disorders.
|
(a)(1) On and after the effective date of this amendatory |
Act of the 97th General Assembly,
every insurer which amends, |
delivers, issues, or renews
group accident and health policies |
providing coverage for hospital or medical treatment or
|
services for illness on an expense-incurred basis shall offer |
to the
applicant or group policyholder subject to the insurer's |
standards of
insurability, coverage for reasonable and |
necessary treatment and services
for mental, emotional or |
nervous disorders or conditions, other than serious
mental |
illnesses as defined in item (2) of subsection (b), consistent |
with the parity requirements of Section 370c.1 of this Code.
|
(2) Each insured that is covered for mental, emotional, |
nervous, or substance use
disorders or conditions shall be free |
to select the physician licensed to
practice medicine in all |
its branches, licensed clinical psychologist,
licensed |
clinical social worker, licensed clinical professional |
counselor, licensed marriage and family therapist, licensed |
speech-language pathologist, or other licensed or certified |
professional at a program licensed pursuant to the Illinois |
Alcoholism and Other Drug Abuse and Dependency Act of
his |
choice to treat such disorders, and
the insurer shall pay the |
covered charges of such physician licensed to
practice medicine |
|
in all its branches, licensed clinical psychologist,
licensed |
clinical social worker, licensed clinical professional |
counselor, licensed marriage and family therapist, licensed |
speech-language pathologist, or other licensed or certified |
professional at a program licensed pursuant to the Illinois |
Alcoholism and Other Drug Abuse and Dependency Act up
to the |
limits of coverage, provided (i)
the disorder or condition |
treated is covered by the policy, and (ii) the
physician, |
licensed psychologist, licensed clinical social worker, |
licensed
clinical professional counselor, licensed marriage |
and family therapist, licensed speech-language pathologist, or |
other licensed or certified professional at a program licensed |
pursuant to the Illinois Alcoholism and Other Drug Abuse and |
Dependency Act is
authorized to provide said services under the |
statutes of this State and in
accordance with accepted |
principles of his profession.
|
(3) Insofar as this Section applies solely to licensed |
clinical social
workers, licensed clinical professional |
counselors, licensed marriage and family therapists, licensed |
speech-language pathologists, and other licensed or certified |
professionals at programs licensed pursuant to the Illinois |
Alcoholism and Other Drug Abuse and Dependency Act, those |
persons who may
provide services to individuals shall do so
|
after the licensed clinical social worker, licensed clinical |
professional
counselor, licensed marriage and family |
therapist, licensed speech-language pathologist, or other |
|
licensed or certified professional at a program licensed |
pursuant to the Illinois Alcoholism and Other Drug Abuse and |
Dependency Act has informed the patient of the
desirability of |
the patient conferring with the patient's primary care
|
physician and the licensed clinical social worker, licensed |
clinical
professional counselor, licensed marriage and family |
therapist, licensed speech-language pathologist, or other |
licensed or certified professional at a program licensed |
pursuant to the Illinois Alcoholism and Other Drug Abuse and |
Dependency Act has
provided written
notification to the |
patient's primary care physician, if any, that services
are |
being provided to the patient. That notification may, however, |
be
waived by the patient on a written form. Those forms shall |
be retained by
the licensed clinical social worker, licensed |
clinical professional counselor, licensed marriage and family |
therapist, licensed speech-language pathologist, or other |
licensed or certified professional at a program licensed |
pursuant to the Illinois Alcoholism and Other Drug Abuse and |
Dependency Act
for a period of not less than 5 years.
|
(b)(1) An insurer that provides coverage for hospital or |
medical
expenses under a group or individual policy of accident |
and health insurance or
health care plan amended, delivered, |
issued, or renewed on or after the effective
date of this |
amendatory Act of the 100th General Assembly shall provide |
coverage
under the policy for treatment of serious mental |
illness and substance use disorders consistent with the parity |
|
requirements of Section 370c.1 of this Code. This subsection |
does not apply to any group policy of accident and health |
insurance or health care plan for any plan year of a small |
employer as defined in Section 5 of the Illinois Health |
Insurance Portability and Accountability Act.
|
(2) "Serious mental illness" means the following |
psychiatric illnesses as
defined in the most current edition of |
the Diagnostic and Statistical Manual
(DSM) published by the |
American Psychiatric Association:
|
(A) schizophrenia;
|
(B) paranoid and other psychotic disorders;
|
(C) bipolar disorders (hypomanic, manic, depressive, |
and mixed);
|
(D) major depressive disorders (single episode or |
recurrent);
|
(E) schizoaffective disorders (bipolar or depressive);
|
(F) pervasive developmental disorders;
|
(G) obsessive-compulsive disorders;
|
(H) depression in childhood and adolescence;
|
(I) panic disorder; |
(J) post-traumatic stress disorders (acute, chronic, |
or with delayed onset); and
|
(K) eating disorders, including, but not limited to, |
anorexia nervosa, bulimia nervosa, pica, rumination |
disorder, avoidant/restrictive food intake disorder, other |
specified feeding or eating disorder (OSFED), and any other |
|
eating disorder contained in the most recent version of the |
Diagnostic and Statistical Manual of Mental Disorders |
published by the American Psychiatric Association. |
(2.5) "Substance use disorder" means the following mental |
disorders as defined in the most current edition of the |
Diagnostic and Statistical Manual (DSM) published by the |
American Psychiatric Association: |
(A) substance abuse disorders; |
(B) substance dependence disorders; and |
(C) substance induced disorders. |
(3) Unless otherwise prohibited by federal law and |
consistent with the parity requirements of Section 370c.1 of |
this Code, the reimbursing insurer, a provider of treatment of
|
serious mental illness or substance use disorder shall furnish |
medical records or other necessary data
that substantiate that |
initial or continued treatment is at all times medically
|
necessary. An insurer shall provide a mechanism for the timely |
review by a
provider holding the same license and practicing in |
the same specialty as the
patient's provider, who is |
unaffiliated with the insurer, jointly selected by
the patient |
(or the patient's next of kin or legal representative if the
|
patient is unable to act for himself or herself), the patient's |
provider, and
the insurer in the event of a dispute between the |
insurer and patient's
provider regarding the medical necessity |
of a treatment proposed by a patient's
provider. If the |
reviewing provider determines the treatment to be medically
|
|
necessary, the insurer shall provide reimbursement for the |
treatment. Future
contractual or employment actions by the |
insurer regarding the patient's
provider may not be based on |
the provider's participation in this procedure.
Nothing |
prevents
the insured from agreeing in writing to continue |
treatment at his or her
expense. When making a determination of |
the medical necessity for a treatment
modality for serious |
mental illness or substance use disorder, an insurer must make |
the determination in a
manner that is consistent with the |
manner used to make that determination with
respect to other |
diseases or illnesses covered under the policy, including an
|
appeals process. Medical necessity determinations for |
substance use disorders shall be made in accordance with |
appropriate patient placement criteria established by the |
American Society of Addiction Medicine. No additional criteria |
may be used to make medical necessity determinations for |
substance use disorders.
|
(4) A group health benefit plan amended, delivered, issued, |
or renewed on or after the effective date of this amendatory |
Act of the 97th General Assembly:
|
(A) shall provide coverage based upon medical |
necessity for the
treatment of mental illness and substance |
use disorders consistent with the parity requirements of |
Section 370c.1 of this Code; provided, however, that in |
each calendar year coverage shall not be less than the |
following:
|
|
(i) 45 days of inpatient treatment; and
|
(ii) beginning on June 26, 2006 (the effective date |
of Public Act 94-921), 60 visits for outpatient |
treatment including group and individual
outpatient |
treatment; and |
(iii) for plans or policies delivered, issued for |
delivery, renewed, or modified after January 1, 2007 |
(the effective date of Public Act 94-906),
20 |
additional outpatient visits for speech therapy for |
treatment of pervasive developmental disorders that |
will be in addition to speech therapy provided pursuant |
to item (ii) of this subparagraph (A); and
|
(B) may not include a lifetime limit on the number of |
days of inpatient
treatment or the number of outpatient |
visits covered under the plan.
|
(C) (Blank).
|
(5) An issuer of a group health benefit plan may not count |
toward the number
of outpatient visits required to be covered |
under this Section an outpatient
visit for the purpose of |
medication management and shall cover the outpatient
visits |
under the same terms and conditions as it covers outpatient |
visits for
the treatment of physical illness.
|
(5.5) An individual or group health benefit plan amended, |
delivered, issued, or renewed on or after the effective date of |
this amendatory Act of the 99th General Assembly shall offer |
coverage for medically necessary acute treatment services and |
|
medically necessary clinical stabilization services. The |
treating provider shall base all treatment recommendations and |
the health benefit plan shall base all medical necessity |
determinations for substance use disorders in accordance with |
the most current edition of the American Society of Addiction |
Medicine Patient Placement Criteria. |
As used in this subsection: |
"Acute treatment services" means 24-hour medically |
supervised addiction treatment that provides evaluation and |
withdrawal management and may include biopsychosocial |
assessment, individual and group counseling, psychoeducational |
groups, and discharge planning. |
"Clinical stabilization services" means 24-hour treatment, |
usually following acute treatment services for substance |
abuse, which may include intensive education and counseling |
regarding the nature of addiction and its consequences, relapse |
prevention, outreach to families and significant others, and |
aftercare planning for individuals beginning to engage in |
recovery from addiction. |
(6) An issuer of a group health benefit
plan may provide or |
offer coverage required under this Section through a
managed |
care plan.
|
(7) (Blank).
|
(8)
(Blank).
|
(9) With respect to substance use disorders, coverage for |
inpatient treatment shall include coverage for treatment in a |
|
residential treatment center licensed by the Department of |
Public Health or the Department of Human Services. |
(c) This Section shall not be interpreted to require |
coverage for speech therapy or other habilitative services for |
those individuals covered under Section 356z.15
of this Code. |
(d) The Department shall enforce the requirements of State |
and federal parity law, which includes ensuring compliance by |
individual and group policies; detecting violations of the law |
by individual and group policies proactively monitoring |
discriminatory practices; accepting, evaluating, and |
responding to complaints regarding such violations; and |
ensuring violations are appropriately remedied and deterred. |
(e) Availability of plan information. |
(1) The criteria for medical necessity determinations |
made under a group health plan with respect to mental |
health or substance use disorder benefits (or health |
insurance coverage offered in connection with the plan with |
respect to such benefits) must be made available by the |
plan administrator (or the health insurance issuer |
offering such coverage) to any current or potential |
participant, beneficiary, or contracting provider upon |
request. |
(2) The reason for any denial under a group health plan |
(or health insurance coverage offered in connection with |
such plan) of reimbursement or payment for services with |
respect to mental health or substance use disorder benefits |
|
in the case of any participant or beneficiary must be made |
available within a reasonable time and in a reasonable |
manner by the plan administrator (or the health insurance |
issuer offering such coverage) to the participant or |
beneficiary upon request. |
(f) As used in this Section, "group policy of accident and |
health insurance" and "group health benefit plan" includes (1) |
State-regulated employer-sponsored group health insurance |
plans written in Illinois and (2) State employee health plans. |
(g) (1) As used in this subsection: |
"Benefits", with respect to insurers, means
the benefits |
provided for treatment services for inpatient and outpatient |
treatment of substance use disorders or conditions at American |
Society of Addiction Medicine levels of treatment 2.1 |
(Intensive Outpatient), 2.5 (Partial Hospitalization), 3.1 |
(Clinically Managed Low-Intensity Residential), 3.3 |
(Clinically Managed Population-Specific High-Intensity |
Residential), 3.5 (Clinically Managed High-Intensity |
Residential), and 3.7 (Medically Monitored Intensive |
Inpatient) and OMT (Opioid Maintenance Therapy) services. |
"Benefits", with respect to managed care organizations, |
means the benefits provided for treatment services for |
inpatient and outpatient treatment of substance use disorders |
or conditions at American Society of Addiction Medicine levels |
of treatment 2.1 (Intensive Outpatient), 2.5 (Partial |
Hospitalization), 3.5 (Clinically Managed High-Intensity |
|
Residential), and 3.7 (Medically Monitored Intensive |
Inpatient) and OMT (Opioid Maintenance Therapy) services. |
"Substance use disorder treatment provider or facility" |
means a licensed physician, licensed psychologist, licensed |
psychiatrist, licensed advanced practice registered nurse, or |
licensed, certified, or otherwise State-approved facility or |
provider of substance use disorder treatment. |
(2) A group health insurance policy, an individual health |
benefit plan, or qualified health plan that is offered through |
the health insurance marketplace, small employer group health |
plan, and large employer group health plan that is amended, |
delivered, issued, executed, or renewed in this State, or |
approved for issuance or renewal in this State, on or after the |
effective date of this amendatory Act of the 100th General |
Assembly shall comply with the requirements of this Section and |
Section 370c.1. The services for the treatment and the ongoing |
assessment of the patient's progress in treatment shall follow |
the requirements of 77 Ill. Adm. Code 2060. |
(3) Prior authorization shall not be utilized for the |
benefits under this subsection. The substance use disorder |
treatment provider or facility shall notify the insurer of the |
initiation of treatment. For an insurer that is not a managed |
care organization, the substance use disorder treatment |
provider or facility notification shall occur for the |
initiation of treatment of the covered person within 2 business |
days. For managed care organizations, the substance use |
|
disorder treatment provider or facility notification shall |
occur in accordance with the protocol set forth in the provider |
agreement for initiation of treatment within 24 hours. If the |
managed care organization is not capable of accepting the |
notification in accordance with the contractual protocol |
during the 24-hour period following admission, the substance |
use disorder treatment provider or facility shall have one |
additional business day to provide the notification to the |
appropriate managed care organization. Treatment plans shall |
be developed in accordance with the requirements and timeframes |
established in 77 Ill. Adm. Code 2060. If the substance use |
disorder treatment provider or facility fails to notify the |
insurer of the initiation of treatment in accordance with these |
provisions, the insurer may follow its normal prior |
authorization processes. |
(4) For an insurer that is not a managed care organization, |
if an insurer determines that benefits are no longer medically |
necessary, the insurer shall notify the covered person, the |
covered person's authorized representative, if any, and the |
covered person's health care provider in writing of the covered |
person's right to request an external review pursuant to the |
Health Carrier External Review Act. The notification shall |
occur within 24 hours following the adverse determination. |
Pursuant to the requirements of the Health Carrier External |
Review Act, the covered person or the covered person's |
authorized representative may request an expedited external |
|
review.
An expedited external review may not occur if the |
substance use disorder treatment provider or facility |
determines that continued treatment is no longer medically |
necessary. Under this subsection, a request for expedited |
external review must be initiated within 24 hours following the |
adverse determination notification by the insurer. Failure to |
request an expedited external review within 24 hours shall |
preclude a covered person or a covered person's authorized |
representative from requesting an expedited external review. |
If an expedited external review request meets the criteria |
of the Health Carrier External Review Act, an independent |
review organization shall make a final determination of medical |
necessity within 72 hours. If an independent review |
organization upholds an adverse determination, an insurer |
shall remain responsible to provide coverage of benefits |
through the day following the determination of the independent |
review organization. A decision to reverse an adverse |
determination shall comply with the Health Carrier External |
Review Act. |
(5) The substance use disorder treatment provider or |
facility shall provide the insurer with 7 business days' |
advance notice of the planned discharge of the patient from the |
substance use disorder treatment provider or facility and |
notice on the day that the patient is discharged from the |
substance use disorder treatment provider or facility. |
(6) The benefits required by this subsection shall be |
|
provided to all covered persons with a diagnosis of substance |
use disorder or conditions. The presence of additional related |
or unrelated diagnoses shall not be a basis to reduce or deny |
the benefits required by this subsection. |
(7) Nothing in this subsection shall be construed to |
require an insurer to provide coverage for any of the benefits |
in this subsection. |
(Source: P.A. 99-480, eff. 9-9-15; 100-305, eff. 8-24-17.)
|
Section 99. Effective date. This Act takes effect January |
1, 2019.
|